Germany
Japan
United Kingdom
China
Antibodies
View as table Download
CD49b (ITGA2) human monoclonal antibody, clone B4F12
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Biotin |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Human Ephrin Type A receptor 2 (Clone 1C1)
| Applications | ELISA, FC, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 523.00
2 Weeks
USD 523.00
2 Weeks
Recombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))
| Applications | ELISA, FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
| Applications | ELISA, FC, IHC |
| Reactivities | Chimpanzee, Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-ED-B domain of fibronectin (Clone A2)
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-ED-B domain of fibronectin (Clone G4)
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | ELISA, FC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
| Applications | ELISA, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD80 (Clone IDEC-114 (Galiximab))
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IL-6 receptor (Clone rhPM-1 (Tocilizumab))
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-GM2 ganglioside (Clone L55-81)
| Applications | ELISA, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone 5D12)
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Human, Monkey, Cynomolgus |
| Conjugation | Unconjugated |
Recombinant Anti-Fas (Clone R-125224)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-EGFR (Clone 2F8 (Zalutumumab; HuMax-EGFR))
| Applications | ELISA, FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD80 (Clone 16C10)
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-BRD4 (Clone RAB-C131)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-CBX5 (Clone RAB-C133)
| Applications | ChIP, ELISA |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-CBX1 (Clone RAB-C145)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-PRMT5 (Clone RAB-C136)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-WDR5 (Clone RAB-C223)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-CBX2 (Clone RAB-C238)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-L3MBTL1 (Clone RAB-C213)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-PRDM4 (Clone RAB-C367)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-PRDM9 (Clone RAB-C370)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-PRMT3 (Clone RAB-C372)
| Applications | ChIP, ELISA |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-SETD7 (Clone RAB-C220)
| Applications | ChIP, ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-SFMBT1 (Clone RAB-C396)
| Applications | ChIP, ELISA |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-TDRD3 (Clone RAB-C419)
| Applications | ChIP, ELISA, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-SUV420H2 (Clone RAB-C409)
| Applications | ChIP, ELISA |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-FOXP4 (Clone RAB-S40)
| Applications | ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-FOXP1 (Clone RAB-S37)
| Applications | ELISA, FC, IF |
| Reactivities | Human |
| Conjugation | His Tag |
Recombinant Anti-FOXP2 (Clone RAB-S249)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | His Tag |
Active filters
Reactivities
- Human
Applications
- ELISA
Antibody Hosts
- Human
Filter by
Category
Target Symbol
- TNF (3)
- CD80 (2)
- EGFR (2)
- FN1 (2)
- BRD4 (1)
- CBX1 (1)
- CBX2 (1)
- CBX5 (1)
- CD38 (1)
- CD4 (1)
- CD40 (1)
- CD52 (1)
- CD70 (1)
- EPHA2 (1)
- ERBB2 (1)
- FAS (1)
- FOXP1 (1)
- FOXP2 (1)
- FOXP4 (1)
- GM2 (1)
- IL6R (1)
- ITGA5 (1)
- KMT5C (1)
- L3MBTL1 (1)
- PRDM4 (1)
- PRDM9 (1)
- PRMT3 (1)
- PRMT5 (1)
- SETD7 (1)
- SFMBT1 (1)
- TDRD3 (1)
- TYRP1 (1)
- VEGFA (1)
- WDR5 (1)
Clonalities
Conjugates
Modifications
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (7)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)